Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

ClinicalTrials.gov ID: NCT02680002

Public ClinicalTrials.gov record NCT02680002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blinded, Phase 2 Study to Assess Safety & Immunogenicity of Stored Inactivated Monovalent Influenza A/Vietnam/H5N1 Virus Vaccine Administered Intramuscularly at Different Dose Levels Given With & Without Stored MF59® Adjuvant

Study identification

NCT ID
NCT02680002
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biomedical Advanced Research and Development Authority
Federal
Enrollment
422 participants

Conditions and interventions

Interventions

  • 7.5 mcg H5N1 (stored as monobulk) Biological
  • 15 mcg H5N1 (stored as monobulk) Biological
  • 90 mcg H5N1 (stored as monobulk) Biological
  • 90 mcg H5N1 (stored in vials) Biological
  • MF59 Other
  • MF59 (stored as monobulk) Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2016
Primary completion
May 12, 2016
Completion
Mar 30, 2017
Last update posted
Aug 30, 2020

2016 – 2017

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Radiant Research, Inc. Atlanta Georgia 30328
Clinical Research Advantage, Inc./Ridge Family Practice Council Bluffs Iowa 51503
Johnson County Clin-Trials, Inc. Lenexa Kansas 66219
Central Kentucky Researcch Associates, Inc. Lexington Kentucky 40509
Radiant Research, Inc. Edina Minnesota 55435
Rochester Clinical Research, Inc. Rochester New York 14609

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02680002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02680002 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →